We are live on ! Find out more
RPTP

RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP

Delisted

RPTP was delisted on the 24th of October, 2016.

111 hedge funds and large institutions have $468M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2016 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 26 increasing their positions, 26 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more capital invested

Capital invested by funds: $252M → $468M (+$215M)

80% more call options, than puts

Call options by funds: $17.6M | Put options by funds: $9.77M

62% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 29

19% more funds holding

Funds holding: 93111 (+18)

0% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 26

75% less funds holding in top 10

Funds holding in top 10: 41 (-3)

Holders
111
Holders Change
+18
Holders Change %
+19.35%
% of All Funds
2.96%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.03%
New
47
Increased
26
Reduced
26
Closed
29
Calls
$17.6M
Puts
$9.77M
Net Calls
+$7.86M
Net Calls Change
+$7.28M
Name Holding Trade Value Shares
Change
Change in
Stake
PAMU
26
Pictet Asset Management (UK)
United Kingdom
$3.95M +$195K +27,400 +7%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$3.75M -$266K -37,449 -8%
GP
28
GLG Partners
United Kingdom
$3.59M +$2.84M +400,000 New
Goldman Sachs
29
Goldman Sachs
New York
$3.55M -$16.8M -2,358,228 -86%
KAM
30
Kassirer Asset Management
Ontario, Canada
$3.26M +$2.59M +363,700 New
Allianz Asset Management
31
Allianz Asset Management
Germany
$3.26M +$21.4K +3,009 +0.8%
Charles Schwab
32
Charles Schwab
California
$3.06M +$552K +77,635 +29%
BBP
33
Banco BTG Pactual
Brazil
$3.04M +$2.41M +338,889 New
BIM
34
BlackRock Investment Management
Delaware
$2.97M +$3.44K +484 +0.1%
VKH
35
Virtu KCG Holdings
New York
$2.74M +$2.17M +305,798 New
GCL
36
Glazer Capital LLC
New York
$2.7M +$2.14M +301,384 New
ACM
37
Atika Capital Management
New York
$2.67M -$7.54M -1,059,800 -78%
OAM
38
Oxford Asset Management
United Kingdom
$2.39M +$1.89M +266,283 New
Barclays
39
Barclays
United Kingdom
$2.27M +$1.8M +253,084 New
FNYS
40
First New York Securities
New York
$2.13M +$1.69M +237,500 New
CCMH
41
Cornerstone Capital Management Holdings
New York
$1.65M -$1.77M -248,403 -58%
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$1.62M +$12.1K +1,700 +0.9%
PCM
43
Prelude Capital Management
New York
$1.54M +$1.12M +157,458 +1,086%
Group One Trading
44
Group One Trading
Illinois
$1.44M -$1.56M -218,869 -58%
BA
45
BlackRock Advisors
Delaware
$1.28M -$920K -129,350 -48%
Tudor Investment Corp
46
Tudor Investment Corp
Connecticut
$1.28M +$244K +34,269 +32%
TA
47
Teachers Advisors
New York
$1.23M
Swiss National Bank
48
Swiss National Bank
Switzerland
$1.15M -$34.8K -4,900 -4%
Renaissance Technologies
49
Renaissance Technologies
New York
$1.14M +$899K +126,480 New
PP
50
PDT Partners
New York
$1.07M -$271K -38,100 -24%

RPTP Hedge Fund Activity: Q3 2016 in Review

111 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q3 2016, worth a combined $468M — up 85% from $252M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new RPTP positions and 29 closed out — a net gain of 18 holders — while 26 added to existing stakes and 26 trimmed.

The largest buyer was AQR Arbitrage, opening a new position worth an estimated $28.9M. The largest seller was Broadfin Capital, cutting an estimated $41.1M.

  • 111 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q3 2016, up from 93 in Q2 2016.
  • Funds reported $468M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q3 2016, up 85% quarter-over-quarter.
  • 47 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q3 2016 and 29 closed out, a net change of +18 holders.
  • The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q3 2016 was AQR Arbitrage, an estimated $28.9M added.
  • The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q3 2016 was Broadfin Capital, an estimated $41.1M sold.

Based on aggregated 13F filings for Q3 2016.